Polyrizon Expands U.S. Patent Claims for Intranasal Drug Delivery Platform
PLRZ has more than doubled off its 52-week low of $2.88.
Summary
Polyrizon Ltd. announced the submission of amended claims for its U.S. patent application, broadening protection for its intranasal drug delivery platform to include systems and methods of use.
Key Events · Product Development and Regulatory · PLRZ
-
U.S. Patent Claims Expanded
Polyrizon submitted amended claims for its U.S. patent application, broadening protection for its intranasal drug delivery platform.
-
Scope Includes Delivery Systems & Methods
The expanded claims now cover drug delivery systems and methods of use, enhancing the platform's potential applicability and value.
-
Strengthens IP Portfolio
This move aligns with the company's strategy to strengthen its global intellectual property, following a recent European patent application.
Analysis · PLRZ · Industrial Applications And Services
This filing details Polyrizon's strategic move to strengthen its intellectual property by expanding the scope of its U.S. patent application. The amended claims now cover not only the core mucoadhesive composition but also the drug delivery systems and methods of use, which is crucial for a development-stage biotech. This expansion enhances the potential value and applicability of their Trap & Target (T&T) platform, aiming to improve drug absorption and efficacy through prolonged residence time and enhanced mucosal interaction. This follows a recent European patent application filing on April 27, 2026, indicating a focused effort to build a robust global IP portfolio for its core technology.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 28.9% of the 1476 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PLRZ was trading at $15.67 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $28.5M. The 52-week trading range was $2.88 to $2,235.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.